Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Suggestion of Intrathecal Isobaric Bupivacaine for Aging and Overweight Patients
TCTR20220508002Active, not recruiting
- Sponsor
- N/A
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of bupivacaine, sponsored by N/A. Started May 2022; status: active, not recruiting.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on TCTR20220508002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220508002.